Renovo News
-
17th March 2008Renovo Group plc (LSE: RNVO), the biopharmaceutical company developing drugs for the reduction of scarring and acceleration of healing, announces that Professor Mark Ferguson, Chief Executive Off...read more
-
3rd March 2008An analyst briefing will be held at 14:00 UK time today at Buchanan Communications, 45 Moorfields London, EC2Y 9AE....read more
-
15th February 2008Ahead of its Annual General Meeting to be held at the offices of Buchanan Communications, 45 Moorfields, London EC2Y 9AE on 20 February 2008, Renovo Group plc (LSE: RNVO) today publishes its firs...read more
-
10th October 2007RENOVO WINS EUROPEAN BIOTECHNICA AWARD...read more
-
12th September 2007RENOVO GROUP PLC(“Renovo” or “the Company”)...read more
-
28th August 2007RENOVO GROUP PLC(“Renovo” or “the Company”) APPOINTMENT OF DR JOHN HUTCHISON AS CHIEF MEDICAL OFFICER AND EXECUTIVE BOARD DIRECTOR...read more
-
8th August 2007Renovo Group plc (LSE: RNVO) (the "Company") today announces that the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 (HSR) with respect to its Juvista development ...read more